Selected article for: "acute respiratory and low tidal volume"
Author: Jacobson, Jennifer; Antony, Kathleen; Beninati, Michael; Alward, William; Hoppe, Kara K.
Title: Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report
  • Cord-id: w6xcwjtf
  • Document date: 2020_11_25
    • ID: w6xcwjtf
    Snippet: Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at 26 weeks of gestation with acute respiratory distress syndrome secondary to COVID-19 infection treated with dexamethasone, remdesivir, convalescent plasma and mechanical ventilation. Cesarean delivery was performed at 29 weeks due to worsening maternal status. This case offers insight into the assessment and successful use of tr
    Document: Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at 26 weeks of gestation with acute respiratory distress syndrome secondary to COVID-19 infection treated with dexamethasone, remdesivir, convalescent plasma and mechanical ventilation. Cesarean delivery was performed at 29 weeks due to worsening maternal status. This case offers insight into the assessment and successful use of treatment strategies, including dexamethasone, remdesivir, convalescent plasma, early prone positioning, conservative fluid management, permissive hypoxia and low tidal volume parameters with ventilator support for pregnancies affected by severe COVID-19 infection.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and low remain: 1
    • acute ards respiratory distress syndrome and low tidal volume strategy: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung function improve: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and lung protection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute hypoxic respiratory failure and lopinavir ritonavir: 1
    • adrenal insufficiency and lung function: 1
    • lopinavir ritonavir and low remain: 1
    • lopinavir ritonavir and lung function: 1, 2, 3, 4, 5
    • lopinavir ritonavir and lung function improve: 1
    • low tidal volume strategy and lung function: 1
    • low tidal volume strategy and lung function improve: 1